Company / Return on Assets (ROA)
Amneal Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
2.0%
FY2025
5-year range
-15.3% / 2.0%
FY2021-FY2025
Trend
+158.7%
vs FY2024
Sector context
#53 of 213
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s return on assets (roa) of 2.0% is higher than 75% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -15.3% in FY2021 to 2.0% in FY2025.
Based on SEC 10-K filings.
2.0% in FY2025 with a 5-year CAGR of +2.5%. Top quartile in the Health Care sector.
Improved from 0.4% to 2.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +9.1pp
- 5-Year Change
- +2.5pp
- 10-Year Change
- -
Sector benchmark
+108.1% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 158.7% year-over-year.
- Currently 26.1pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.0% | +158.7% |
| FY2024 | -3.3% | -978.9% |
| FY2023 | 0.4% | +105.3% |
| FY2022 | -7.1% | +53.5% |
| FY2021 | -15.3% | -3026.5% |
| FY2020 | -0.5% | - |
| FY2019 | 0.0% | - |
| FY2018 | 0.0% | - |
| FY2017 | 0.0% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026